A no-deal Brexit presents risks to the NHS and care homes despite extensive government planning, a watchdog says. The National Audit Office praised the government for the “enormous amount of work” that had been done but said there were still “significant” gaps. The extra shipping capacity government was buying to bring medicines into ports other… Read More: No-deal Brexit ‘still risk to NHS and care sector’ »
Following recent statewide bans on specific varieties of e-cigarettes as a result of hundreds of illnesses and several deaths across the country, new findings published in Scientific Reports are shedding light on how some e-cig flavors could worsen symptoms of asthma and other respiratory diseases, reports EurekAlert! For the study, researchers from Australia and the… Read More: Certain E-Cigs May Aggravate Asthma »
Valisure: “Valisure Citizen Petition on Ranitidine.” Sandoz Inc.: “Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product.” Bloomberg: “Carcinogen in Zantac Leads to Another Shipment Halt, Recall.” Health Canada: “Health Canada requests that companies stop distributing ranitidine drugs in… Read More: Heartburn Drugs and Cancer: What Are the Risks? »
A Rite Aid store on Jonestown, Road in Harrisburg, PA Rite Aid photo Rite Aid reported $ 78 million in losses in the company’s fiscal second quarter amid a competitive reimbursement environment for prescription drugs in the early days for the drugstore chain’s new chief executive. Heyward Donigan, a longtime healthcare executive, last month replaced… Read More: More Losses At Rite Aid As New CEO Takes Charge »